Biodesix, Inc. (NASDAQ:BDSX) Q3 2025 Earnings Call Transcript
Christopher Brinzey: Thank you, operator, and good afternoon, everyone. Today, Biodesix released results from the third quarter of 2025.
Biodesix Inc (BDSX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Birchview Capital Matthew Strobeck | 286,804 | $1,950,267 | 1.14% | |
| 2. | SilverArc Capital Devesh Gandhi | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.80 | 20,000 | $236,064.00 | 1,563,210 | 2026-01-26 | Filing | |
| $11.81 | 80,000 | $944,672.00 | 1,543,210 | 2026-01-23 | Filing | |
| $10.96 | 82,465 | $903,560.76 | 1,463,210 | 2026-01-22 | Filing | |
| $7.04 | 142,045 | $999,996.80 | 1,380,745 | 2025-09-19 | Filing | |
| $6.17 | 3,056 | $18,853.99 | 1,238,700 | 2025-09-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.08 | 584 | $5,889.11 | 8,885 | 2026-02-10 | Filing | |
| $10.08 | 101 | $1,018.49 | 1,234 | 2026-02-10 | Filing | |
| $10.08 | 3,559 | $35,889.31 | 45,413 | 2026-02-10 | Filing | |
| $10.08 | 941 | $9,489.14 | 15,297 | 2026-02-10 | Filing | |
| $10.08 | 540 | $5,445.41 | 9,387 | 2026-02-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 327,824 | $2,229,203 | 0.22% | |
| 2. | 262,425 | $1,784,490 | 0% | |
| 3. | 192,138 | $1,306,538 | 0% | |
| 4. | 112,344 | $763,939 | 0.43% | |
| 5. | 44,783 | $304,524 | 0.24% |
News See All
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers
Biodesix Inc. (NASDAQ:BDSX) is one of the best penny stocks under $1 to buy now. On June 10, Biodesix announced a new partnership with the Association of Pulmonary Advanced Practice Providers/APAPP.
12 Best Penny Stocks Under $1 to Buy Now
On July 18, Greg Tuorto of Goldman Sachs joined CNBC's 'Closing Bell' to state that the small-cap market is starting to show signs of life.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix's Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Q4 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 Penny Stocks with Insider Buying in 2025
Insider trading can be a reliable signal for gauging the degree of confidence that management has in the future of their company.
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Biodesix, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix Q2 2024 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Biodesix Q1 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
